4ª Prorroga Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid
Deadline:N/A
Contract award
Estimated value
€2,434,682.33
Contract type
Dynamic purchasing system
Duration
6 months
Bidders
Awarded bidders
Name
Price
BIOGEN SPAIN S.L.